Ajinomoto Althea, Inc. – FDA 483, Feb 7, 2019
Ajinomoto Althea, Inc. in San Diego, CA, a sterile product manufacturer, was cited for multiple deficiencies during an FDA inspection. Key issues include inadequate equipment design leading to product vials falling, insufficient investigation into discrepancies and particulate defects, and unrepresentative sampling of drug products. Additionally, the firm failed to adequately validate aseptic processes, control temperature/humidity alarms, and maintain strict control over the storage and access of labeling materials.
ID · e1378dd5-40d2-4f08-91f2-466a36441ce1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.